SimBioSys and Ferrum Health Partner to Expand Access to AI Surgical Planning Tools

July 23, 2026
SimBioSys has partnered with Ferrum Health to make its FDA-cleared TumorSight Viz platform available through Ferrum's Model Hub, improving deployment and management of AI surgical planning capabilities across U.S. health systems.

SimBioSys has partnered with Ferrum Health to broaden access to its FDA-cleared TumorSight Viz platform through Ferrum's Model Hub, announced in a press release.

TumorSight Viz converts standard breast MRI scans into patient-specific 3D visualizations to assist surgeons in planning procedures. Through integration with Ferrum’s Model Hub, hospitals can deploy and manage the tool within existing infrastructure, enabling centralized oversight, monitoring, and scalability across clinical environments.

Ferrum’s platform supports the deployment of AI applications across healthcare systems, while TumorSight Viz brings a focus on breast surgical planning by generating anatomy-specific visualizations. The companies intend to accelerate access to these AI tools in more institutions, enhancing the ability of surgeons to make informed, context-rich decisions during surgical planning.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Enterprise AI Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Enterprise

07/23
Sentinel Group Expands My Financial Journey with Financial Finesse AI Hub
07/23
Element Fleet Management Introduces DigiAdvisor AI Tool for Fleet Decision Making
07/23
Pentera and Recorded Future Partner for Threat Intelligence Validation
07/23
Deloitte Expands Industry Solution Studios to Accelerate AI Implementation
07/23
Trooly Raises $20 Million and Launches AI Research Platform for In-Depth Consumer Interviews

More from: Life Sciences

07/23
DarioHealth Prices $23.5 Million Stock Offering at Market Value
07/23
Health Endeavors Launches AI Care Suite and Receives Investment from Decathlon Capital Partners
07/23
Dassault Systèmes to Acquire ArisGlobal from Nordic Capital
07/23
Agilisium Named Select Services Partner in Anthropic’s Claude Partner Network
07/23
Tally and Liminal Partner to Automate Specialty Healthcare Billing with AI

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more

You May Also Like